News
ULIHF
1.750
NaN%
--
United Laboratories’ Antibiotic Product Passes Consistency Evaluation
TipRanks · 11/26 09:10
United Laboratories Announces Vesting of Award Shares
TipRanks · 11/13 14:38
The United Laboratories International Holdings (ULIHF) Gets a Buy from First Shanghai Securities
TipRanks · 11/11 05:05
United Laboratories Advances TUL01101 Tablets to Phase III Trials
TipRanks · 11/10 15:09
United Laboratories Acquires Award Shares for Share Scheme
TipRanks · 11/05 11:08
United Laboratories Announces Interim Dividend for 2025
Barchart · 10/03 09:18
The United Laboratories Announces 2025 Interim Dividend Payment
TipRanks · 10/02 14:07
United Laboratories Gains Approval for Weight Loss Drug Trial
TipRanks · 09/30 08:39
The United Laboratories Reports Strong H1 2025 Results
TipRanks · 09/24 03:51
The United Laboratories Enhances ESG Efforts with New Sustainability Committee
TipRanks · 09/21 10:38
Weekly Report: what happened at ULIHF last week (0908-0912)?
Weekly Report · 09/15 12:07
Weekly Report: what happened at ULIHF last week (0901-0905)?
Weekly Report · 09/08 12:09
Jefferies Remains a Buy on The United Laboratories International Holdings (ULIHF)
TipRanks · 09/05 15:15
Weekly Report: what happened at ULIHF last week (0825-0829)?
Weekly Report · 09/01 12:03
The United Laboratories Reports Strong Interim Financial Results
TipRanks · 08/28 15:15
The United Laboratories Announces Interim Dividend for 2024
TipRanks · 08/28 15:12
The United Laboratories Announces Board and Committee Roles
TipRanks · 08/28 13:43
Weekly Report: what happened at ULIHF last week (0818-0822)?
Weekly Report · 08/25 12:19
Weekly Report: what happened at ULIHF last week (0811-0815)?
Weekly Report · 08/18 12:07
The United Laboratories Projects Significant Profit Increase for H1 2025
TipRanks · 08/18 10:39
More
Webull provides a variety of real-time ULIHF stock news. You can receive the latest news about United Labs Int Hlds Ltd through multiple platforms. This information may help you make smarter investment decisions.
About ULIHF
The United Laboratories International Holdings Limited is an investment holding company principally engaged in the sales of intermediate products, bulk medicine and finished products. The Company operates its business through three segments. The Intermediate Products segment is engaged in the sale of intermediate products. The Bulk Medicine segment is engaged in the sale of bulk medicine. The Finished Products segment is engaged in the sale of antibiotics finished products, non-antibiotics finished products and capsule casings. Through its subsidiaries, the Company is also engaged in the production and sale of organic fertilizer.